title: Following a trial that stopped early: what next for adjuvant hepatic intra-arterial iodine-131 lipiodol in resectable hepatocellular carcinoma?
authors.forename: S B
authors.initials: SB
authors.lastname: Tan
authors.forename: D
authors.initials: D
authors.lastname: Machin
authors.forename: Y B
authors.initials: YB
authors.lastname: Cheung
authors.forename: Y F A
authors.initials: YF
authors.lastname: Chung
authors.forename: B C
authors.initials: BC
authors.lastname: Tai
authors.forename: D
authors.initials: D
authors.lastname: Machin
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000532:radiotherapy* / Q000601:surgery; D016461:Chemoembolization, Therapeutic; D006499:Hepatic Artery; D006801:Humans; D007269:Injections, Intra-Arterial; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007459:Iodized Oil / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
chemical_list: D007457:Iodine Radioisotopes; D007459:Iodized Oil